TME Pharma
Phase 1pharma, therapeutics, glioblastoma, brain cancer, GBM, pancreatic cancer, TME, tumor microenvironment, GLORIA, NOX-A12, NOX-E36, anti-cancer, clinical trial
Founded
2000
Focus
Small Molecules
About
pharma, therapeutics, glioblastoma, brain cancer, GBM, pancreatic cancer, TME, tumor microenvironment, GLORIA, NOX-A12, NOX-E36, anti-cancer, clinical trial
Funding History
3Total raised: $50M
IPO$15MUndisclosedJul 15, 2021
Series B$25MUndisclosedJun 15, 2018
Series A$10MUndisclosedJun 15, 2015
Company Info
TypePrivate
Founded2000
LocationBerlin, Germany
StagePhase 1
Contact
SIMILAR COMPANIES
300Microns
Pre-clinical · Munich
BetaSense
Pre-clinical · Berlin
AB Diagnostic Systems
Pre-clinical · Jena
bbi-biotech
Pre-clinical · Berlin
Mireca Medicines
Pre-clinical · Munich
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile